세계의 외부 비강 확장기 시장(2024-2031년)

Market Overview

The Global External Nasal Dilators Market reached US$ 179.80 million in 2023 and is expected to reach US$ 273.22 million by 2031, growing at a CAGR of 5.5% during the forecast period 2024-2031.

External nasal dilators (ENDs) are adhesive bands containing a central elastic strip that reduce nasal resistance and inspiratory pressure by preventing the collapse of the lateral nasal vestibule. ENDs are applied horizontally to the skin of the nasal dorsum.

The external nasal dilator is a plastic or silicone device. It is 2 strips of adhesive with spring-like bands that expand the nasal passages by lifting and holding open the sides of the nose. This action decreases nasal airway resistance and allows improved airflow.

The market for external nasal dilators is likely to grow due to the increasing prevalence of snoring, sleep-related disorders & clogged noses among people as well as the demand for non-invasive treatment solutions in this area.

Market Dynamics: Drivers

Growing Awareness of Snoring and Sleep Disorders

Several factors contribute to the overall demand for the global external nasal dilator market. As the risks of snoring and sleep disorders to health become more widely known, people are looking for ways to breathe better while they sleep non-invasively. Advancements in external nasal dilators are advocated as tools to decrease snoring and facilitate respiration, contributing to market growth.

A lot of people look for non-invasive methods to deal with problems concerning breathing in ahead such as nasal congestion and restriction. External nasal dilators are simple and non-surgical options to move the area of the nostrils opening to reduce nasal breathing difficulties.

Moreover, major players in the U.S. introducing the new awareness program would propel this market growth. In February 2023, the American Academy of Sleep Medicine launched "More than a Snore" to raise awareness of obstructive sleep apnea and snoring. This campaign aims to raise national awareness of sleep apnea and encourage undiagnosed patients to advocate for themselves and their treatment.

In addition, nasal dilators are frequently used by athletes and those who exercise to improve their performance. These strips are thought to promote oxygen intake and ventilation, which could enhance endurance and general performance.

In general, external nasal dilators are simple to use and don't involve any special training or medication. Their appeal is attributed to their convenience since consumers can implement them without requiring expert guidance. The over-the-counter versions of external nasal dilators are widely accessible in pharmacies, grocery stores, and online retailers. They are a practical option for anyone looking for relief from nasal congestion and related problems because of their easy accessibility.

Restraints

Factors such as the high cost of the devices, lack of reusability of dilators, discomfort due to skin irritation from the adhesive, lack of awareness and adoption, competition from alternative solutions, limited product options, and their limited effectiveness for certain types of snoring these are expected to hamper the market.

Segment Analysis

The global external nasal dilator market is segmented based on product type, application, age group, sales channel, and region.

The nasal congestion segment accounted for approximately 67.4% of the global external nasal dilator market share

The nasal congestion segment is expected to hold the largest market share over the forecast period. Nasal congestion occurs when the nasal passages and the tissues around them as well as blood vessels swell due to excessive fluids. The blocked nose condition comes from this irritation that also gives one a sense of complexation or closure in the nostrils. For infants who cannot be fed due to the congestion or children whose sleep is disturbed by it, a child's stuffy nose could be very distressing.

The more extended their nasal cavity is, the folks with blocked noses get immensely alleviated by that alone. For instance, Bausch Health Companies Inc. revealed on May 2023 that RYALTRIS, a new medication combining mometasone furoate nasal spray with olopatadine hydrochloride can now be found throughout Canada.

Health Canada has authorized RYALTRIS for symptomatic medical management of adults, adolescents, and children six years of age and above having mild to severe spring allergic sinusitis (SAR) with related vision problems. The need for external nasal dilators is rising along with the frequency of nasal congestion, which is fueling the expansion of the external nasal dilator market globally throughout the forecast period.

Geographical Analysis

North America accounted for approximately 41.3% of the global external nasal dilator market share

North America region is expected to hold the largest market share over the forecast period due to the high frequency of long-term sinusitis, reputable suppliers, and rising knowledge of the advantages of external nasal dilatation over alternative techniques.

In the United States, obstructive sleep apnea will affect around 30 million persons by 2023. Roughly 80% of these cases go undetected, resulting in health care costs, decreased productivity at work, and workplace and auto accidents costing the United States more than $149 billion yearly.

Sleep problems can reduce productivity at work and have major health repercussions. According to CDC projections from August 2023, nearly one-third of adult Americans sleep fewer hours than recommended and sleep disorders represent a major public health emergency.

Additionally, the cost of healthcare has increased as a result of the growing prevalence of chronic diseases in North America. Due to the high prevalence of snoring, chronic sinusitis, and rhinosinusitis, North America is expected to have the highest revenue share in the global external nasal dilator market, which in turn drives the regional market during the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global external nasal dilator market. The pandemic affected the manufacture and delivery of a variety of commodities, including medical equipment like nasal strips and external nasal dilators, by upsetting global supply networks.

It's possible that lockdowns, travel restrictions, and labor scarcity contributed to supply and manufacturing delays. There may have been changes in consumer behavior during the epidemic, such as a greater emphasis on wellness and health items. It's possible that some people have become more interested in devices like external nasal dilators to breathe easier and sleep better.

Market Segmentation

By Product Type

• Adhesive Nasal Dilator
• Spring Nasal Dilator
• Nasal Strips
• Nasal Clips

By Application

• Nasal Congestion
• Snoring
• Athletic Nasal Dilation
• Sleep Apnea
• Others

By Age Group

• Adults
• Pediatrics

By Sales Channel

• End-User
• Hospital Pharmacies
• Sports and Fitness Centers
• Retail Pharmacies
• Online Pharmacies
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• France
• Spain
• Italy
• Rest of Europe
• South America
• Brazil
• Argentina
• Rest of South America
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the external nasal dilator market include GlaxoSmithKline Plc, SleepRight, Health Right Products LLC, Walmart Inc, Airware Labs, Walgreen Co, SHREYAAS HEALTH CARE PVT LTD, Nasilator, Rhinomed Limited, McKeon Products, Inc and among others.

Key Developments

• In April 2024, Intake Breathing, a leading provider of innovative breathing solutions, announced the launch of its groundbreaking Intake Breathing nasal dilator. This two-part nasal dilator system is designed to dramatically open the nasal passages, allowing for improved breathing, deeper sleep, and enhanced overall well-being.
• In February 2023, Johnson & Johnson MedTech introduced the RELIEVA TRACT nasal dilation system features a novel mechanism of action that empowers you to create space for your nasal procedures
• In October 2021, Foundation Consumer Healthcare (FCH) announced a partnership with two-time NASCAR champion, Kyle Busch. Together, Busch and FCH are working to increase awareness of the potential benefits and uses of Breathe Right nasal strips.

Why Purchase the Report?

• To visualize the global external nasal dilator market segmentation based on product type, application, age group, sales channel, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of global external nasal dilator market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.

The global external nasal dilator market report would provide approximately 70 tables, 66 figures, and 182 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by Age Group
• 3.4. Snippet by Sales Channel
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing Awareness of Snoring and Sleep Disorders
    • 4.1.1.2. Increased Demand from Athletes Nasal Dilation
    • 4.1.1.3. Technological Advancements in Healthcare
  • 4.1.2. Restraints
    • 4.1.2.1. The High Cost of Devices
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Unmet Needs
• 5.6. PESTEL Analysis
• 5.7. Patent Analysis
• 5.8. SWOT Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• Adhesive Nasal Dilator*
• 7.1. Introduction
• 7.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Spring Nasal Dilator
• 7.4. Nasal Strips
• 7.5. Nasal Clips

9. By Application

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Nasal Congestion*
  • 9.2.1. Introduction
• 9.3. Snoring
• 9.4. Athletic Nasal Dilation
• 9.5. Sleep Apnea
• 9.6. Others

10. By Age Group

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 10.1.2. Market Attractiveness Index, By Age Group
• 10.2. Adults*
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Pediatrics

11. By Sales Channel

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
  • 11.1.2. Market Attractiveness Index, By Sales Channel
• 11.2. Hospitals Pharmacies*
  • 11.2.1. Introduction
  • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 11.3. Sports and Fitness Centers
• 11.4. Retail Pharmacies
• 11.5. Online Pharmacies
• 11.6. Others

12. By Region

• 12.1. Introduction
  • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 12.1.2. Market Attractiveness Index, By Region
• 12.2. North America
  • 12.2.1. Introduction
  • 12.2.2. Key Region-Specific Dynamics
  • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
  • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.2.7.1. U.S.
    • 12.2.7.2. Canada
    • 12.2.7.3. Mexico
• 12.3. Europe
  • 12.3.1. Introduction
  • 12.3.2. Key Region-Specific Dynamics
  • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
  • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.3.7.1. Germany
    • 12.3.7.2. UK
    • 12.3.7.3. France
    • 12.3.7.4. Italy
    • 12.3.7.5. Spain
    • 12.3.7.6. Rest of Europe
• 12.4. South America
  • 12.4.1. Introduction
  • 12.4.2. Key Region-Specific Dynamics
  • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
  • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.4.7.1. Brazil
    • 12.4.7.2. Argentina
    • 12.4.7.3. Rest of South America
• 12.5. Asia-Pacific
  • 12.5.1. Introduction
  • 12.5.2. Key Region-Specific Dynamics
  • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
  • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.5.7.1. China
    • 12.5.7.2. India
    • 12.5.7.3. Japan
    • 12.5.7.4. South Korea
    • 12.5.7.5. Rest of Asia-Pacific
• 12.6. Middle East and Africa
  • 12.6.1. Introduction
  • 12.6.2. Key Region-Specific Dynamics
  • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
  • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel

13. Competitive Landscape

• 13.1. Competitive Scenario
• 13.2. Market Positioning/Share Analysis
• 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

• 14.1. GlaxoSmithKline Plc *
  • 14.1.1. Company Overview
  • 14.1.2. Product Portfolio & Description
  • 14.1.3. Financial Overview
  • 14.1.4. Key Developments
• 14.2. SleepRight
• 14.3. Health Right Products LLC
• 14.4. Walmart Inc
• 14.5. Airware Labs
• 14.6. Walgreen Co
• 14.7. SHREYAAS HEALTH CARE PVT LTD
• 14.8. Nasilator
• 14.9. Rhinomed Limited
• 14.10. McKeon Products, Inc (LIST NOT EXHAUSTIVE)

15. Appendix

• 15.1. About Us and Services
• 15.2. Contact Us